期刊文献+

2型糖尿病患者尿PCX、Nephrin及MCP-1水平在诊断早期肾病中的作用 被引量:5

The significance of detection of urinary podocalyxin, nephrin and monocyte chemoattractant protein-1 for diabetic nephropa-thy in newly diagnosed T2DM patients
原文传递
导出
摘要 目的通过对初诊2型糖尿病患者尿足细胞标志蛋白(PCX)、Nephrin及单核细胞趋化蛋白-1(MCP一1)进行检测,探讨三者对糖尿病肾病早期诊断的临床意义。方法2011年5月至12月本院内分泌科住院初诊2型糖尿病患者132例,分为糖尿病(DM)组[尿白蛋白/尿肌酐(UAlb/UCR)〈30mg/g]56例,糖尿病肾病(DN)组(UAIb/UCR≥30mg/g)76例;正常对照(健康体检者)36例。检测尿Podocalyxi(UPCX)、Nephrin(UNephfin)、MCP-1(UMCP-1)、白蛋白(UAlb)及尿肌酐(UCR)。比较各组UPCX/UCR、UNephrin/UCR、UMCP-1/UCR的差异及2型糖尿病患者上述各指标间的相关性及与UAlb/UCR的相关性,计算糖尿病患者UMCP.1/UCR、UNephrin/UCR、UPCX/UCR及三者联合检测的阳性率,并与UAlb/UCR的阳性率进行比较分析。结果DN组UAlb/UCR、UPCX/UCR和UMCP-1/UCR水平(90.394-59.35;72.11±58.88;104.82±82.77)比DM组(17.50±9.49;37.37±22.83;47.19.4-29。98)和健康对照组(8.934-3.81;9.594-2.28;9.98±3.63)明显升高(P〈0.05);DM组UPCX/UCR、UMCP-1/UCR水平较正常对照组明显升高(P〈0.05);UNephfiin/UCR水平在DN组(83.60±61.61)较DM组(38.74±35.27)明显升高(P〈0.05)。2型糖尿病患者UPCX/UCR、UMCP-1/UCR和UNephrin/UCR水平与UAlb/UCR呈正相关(r=0.619,0.568,0.535,P〈0.05);UPCX/UCR水平与UMCP-1/UCR和UNephrin/UCR呈正相关(r=0.799,0.718,P〈0.05),UNephrin/UCR水平与UMCP-1/UCR水平呈正相关(r=0.635,P〈0.05);UMCP-1/UCR,UNephrin/UCR与UPCX/UCR的阳性率较UAlb/UCR显著升高(x2=9.818,6.673,5.395,P〈0.05)。结论尿PCX、Nephrin和MCP-1单独或联合检测在早期糖尿病肾病诊断中具有重要的应用价值,较尿微量白蛋白更能反映早期糖尿病肾损害。 Objective To explore the significance of combined detection of urinary podocalyxin ( PCX), nephrin and mono- cyte chemoattractant protein-1 ( MCP-1 ) for diabetic nephropathy in newly diagnosed type 2 diabetic patients. Methods A total of 132 newly diagnosed type 2 diabetes mellitus (T2DM) patients and 36 healthy subjects were recruited. The concentrations of urinary PCX ( UPCX), nephrin (UNephrin) and MCP-1 ( UMCP-1 ) were measured with enzyme-linked immunosorbent assay ( ELISA), and urina- ry UAE (UAlb) concentration was measured with turbidimetric immunoassay method. All the results were shown by dividing the urine creatinine (UCR) concentration in the same sample. The comparisons among UAlb/UCR, UPCX/UCR, UNephrin/UCR, and UMCP- I/UCR among groups were investigated. The correlation among UAlb/UCR, UPCX/UCR, UNephrin/UCR and UMCP-1/UCR was in- vestigated in rf2DM patients. The comparison among positive rate of UMCP-1/UCR, UNephrin/UCR, UPCX/UCR and UAlb/UCR was investigated in T2DM patients. Results The levels of UPCX/UCR and UMCP-1/UCR were significantly higher in diabetes melli- tus(DM) group (37. 37 ±22. 83 and 47. 19 ±29. 98, respectively) than in healthy subjects (9. 59 ±2. 28 and 9. 98 ±3.63, respec- tively) ( P 〈 0. 05 ). The levels of UAlb/UCR, UPCX/UCR and UMCP-1/UCR were significantly higher in diabetic nephropathy (DN) group (90.39 ±59.35, 72. 11 +58.88, and 104.82 ±82.77, respectively) than in DM group (17.50 ±9.49, 37.37 ±22. 83, and 47. 19 ± 29.98, respectively) and in healthy subjects (8.93 ± 3.81, 9. 59 ±2. 28, and 9. 98 ± 3.63, respectively) ( P 〈0. 05). The level of UNephrin/UCR was significantly higher in DN group (83.60 ±61.61 ) than in DM group (38. 74 ±35.27) (P 〈0. 05). The levels of UPCX/UCR, UMCP-1/UCR, and UNephrin/UCR were positively correlated with UAlb/UCR ( r =0. 619, 0. 568, and 0. 535, respectively) ( P 〈 0. 05 ) in T2DM patients. The level of UPCX./UCR was positively correlated with the levels of UMCP-1/UCR and UNephrin/UCR ( r =0. 799 and 0. 718, respectively) ( P 〈0.05). The level of UNephrin/UCR was positively correlated with the level of UMCP-1/UCR ( r =0. 635 P 〈0. 05) in T2DM patients. The positive rate of UMCP-1/UCR, UNephrin,/ UCR, and UPCX/UCR was significantly higher than that of UAlb/UCR( X2 = 9. 818, 6. 673, and 5. 395, respectively, P 〈 0. 05 )in T2DM patients. Conclusions The combined detection of urinary PCX, Nephrin and MCP-1 is very important for the early renal dam- age in newly diagnosed type 2 diabetic patients.
出处 《中国医师杂志》 CAS 2014年第2期196-199,共4页 Journal of Chinese Physician
关键词 糖尿病 2型 代谢 唾液糖蛋白类 尿 膜蛋白质类 尿 趋化因子CCL2 尿 糖尿病肾病 诊断 Diabetes mellitus, type 2/metabolism Sialoglycoproteins/urine Membrane proteins/urine Chemokine CCL2/u-rine Diabetic nephropathies/diagnosis
  • 相关文献

参考文献7

  • 1Giunti S,Tesch GH,Pinach S,et al.Monocyte chemoattractantprotein-1 has prosclerotic effects both in a mouse model of experi-mental diabetes and in vitro in human mesangial cells [J].Diabe-tologia,2008,51(1):198-207.
  • 2Ye H,Bai X,Gao H,et al.Urinary podocalyxin positive-elementoccurs in the early stage of diabetic nephropathy and is correlatedwith a clinical diagnosis of diabetic nephropathy [J].J DiabetesComplications,2014,28(1):96-100.
  • 3高旭光,任现国,张沛.裂孔膜蛋白Nephrin和Podocin与后天获得性肾脏疾病关系研究进展[J].中国全科医学,2011,14(14):1617-1619. 被引量:6
  • 4do Nascimento JF,Canani LH,Gerchman F,et al.MessengerRNA levels of podocyte-associated proteins in subjects with differ-ent degrees of glucose tolerance with or without nephropathy [J].BMC Nephrol,2013,14:214.
  • 5You H,Gao T,Cooper TK,et al.Macrophages directly mediatediabetic renal injury [J].Am J Physiol Renal Physiol,2013,305(12):F1719-Fl727.
  • 6Wang QY,Chen FQ.Clinical significance and different levels ofurinary monocyte chemoattractant protein-1 in type 2 diabetes mel-litus[J].Diabetes Res Clin Pract,2009,83(2):215-219.
  • 7Tarabra E,Giunti S,Barutta F,et al.Effect of the monocyte che-moattractant protein-1/CC chemokine receptor 2 system on nephrinexpression in streptozotocin-treated mice and human cultured podo-cytes[J].Diabetes,2009,58(9):2109-2118.

二级参考文献4

共引文献5

同被引文献53

  • 1张希燃,王庆文,陈惠萍,曾彩虹,刘志红.大量蛋白尿型IgA肾病激素疗效及临床病理分析[J].医学研究生学报,2011,24(5):520-525. 被引量:7
  • 2孙丽娜.VEGF、MCP-1、CTGF与糖尿病肾病关系的研究进展[J].慢性病学杂志,2013,13(2):127-129. 被引量:6
  • 3Shaker OG,Sadik NA.Transforming growth factor beta 1and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy[J].Hum Exp Toxicol,2013,32(10):1089-1096.
  • 4Chakkera HA,Hanson RL,Kobes S,et al.Association of variants in the carnosine peptidase 1 gene(CNDP1)withdiabetic nephropathy in American Indians[J].Mol Genet Metab,2011,103(2):185-190.
  • 5Singh DK,Winocour P,Farrington K.Oxidative stress in early diabetic nephropathy:fueling the fire[J].Nat Rev Endocrinol,2011,7(3):176-184.
  • 6Voulgari C,Katsilambros N,Tentolouris N.Smoking cessation predicts amelioration of microalbuminuria in newlydiagnosed type 2 diabetes mellitus:a 1-year prospective study[J].Metabolism.2011,60(10):1456-1464.
  • 7Jiao B,Wang YS,Cheng YN,et al.Valsartan attenuated oxidative stress,decreased MCP-1 and TGF-β1 expression in glomerular mesangial and epithelial cells induced by high-glucose levels[J].Biosci Trends,2011,5(4):173-181.
  • 8Nezu U,Kamiyama H,Kondo Y,et al.Effect of low-protein diet on kidney function in diabetic nephropathy:meta-analysis of randomised controlled trials[J].BMJ Open,2013,3(5).pii:e002934.
  • 9Kopple JD,Feroze U.The effect of obesity on chronic kidney disease[J].J Ren Nutr,2011,21(1):66-71.
  • 10Vejakama P,Thakkinstian A,Lertrattananon D,et al.Reno-protective effects of renin-angiotensin system blockade in type 2diabetic patients:a systematic review and network meta-analysis[J].Diabetologia,2012,55(3):566-578.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部